期刊文献+

间皮素与CA125在卵巢癌中的共定位表达及意义 被引量:5

Expressions and significance of mesothelin and CA125 in human epithelial ovarian cancer
下载PDF
导出
摘要 目的通过对上皮性卵巢癌中间皮素和CA125的表达、定位和细胞黏附的研究,探讨间皮素的功能。方法采用间接免疫荧光双标记染色法、Western blot检测间皮素和CA125的表达及定位,通过人工基底膜成分的黏附实验和EDTA介导的细胞分离实验检测细胞黏附功能。结果间皮素和CA125主要分布在细胞膜,间皮素蛋白在3种细胞系表达由强到弱依次为OVCAR-3、SKOV-3、3AO,3AO和SKOV-3对塑料基质和人工基底膜Matrigel的黏附能力明显低于OVCAR-3(P<0.01)。结论在3种卵巢癌细胞系和卵巢癌组织中间皮素和CA125均有不同程度的表达,存在共定位关系,间皮素的表达与细胞黏附功能相关联。 Objective To investigate the function of mesothelin by analyzing the location, the expressions and the adhesive ability of mesothelin and CA125 in human epithelial ovarian cancer. Methods Mesothelin and CA125 protein expressions and locations in human epithelial ovarian cancer tissues and cell lines were de- termined by indirect imnmnofluorescence double maker and Western blot. Cell adhesive ability was detected by EDTA-induced cell detachment. Results Mesothelin and CA125 were specifically located in cytomembrane of human epithelial ovarian cancer cells. Expressions of mesothelin in the SKOV-3 and 3AO cells were weaker than those in the OVCAR-3. SKOV-3 and 3AO cells adhered less effectively to plastic substance and matrigel than OVCAR-3 (P 〈0. 01 ). Conclusion Different expressions and co-location of mesothelin and CA125 were found in in the 3 kinds of human epithelial ovarian cancer tissues and cell lines. The expression level of mesothe- lin may be related to cell adhesive ability.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2008年第16期1529-1531,共3页 Journal of Third Military Medical University
基金 国家自然科学基金(30572093)~~
关键词 间皮素 CA125 卵巢肿瘤 黏附 mesothelin CA125 ovarian neoplasms adhesion
  • 相关文献

参考文献11

  • 1吴小华,王小玲,张立芳,李利,王永军,郭燕红,郭清,杨波,黎海莉.卵巢上皮性肿瘤组织中间皮素和CA_(125)表达及其相关性研究[J].中华妇产科杂志,2005,40(10):709-711. 被引量:16
  • 2Hassan R, Bullock S, Premkumar A, et al. Phase 1 study of SSIP, a recombinant anti-mesothelin immunotoxin given as a bolus I. V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers [ J]. Clin Cancer Res, 2007, 13 (17) : 5144 - 5149.
  • 3Huang C Y, Cheng W F, Lee C N, et al. Serum mesothelin in epithelial ovarian carcinoma: a new screening marker and prognostic factor [J]. Anticancer Res, 2006, 26(6C) : 4721 -4728.
  • 4陈书成,刘雅坤,吴小华,单保恩,陈兴,孙东霞,王莉.抗人可溶性间皮素相关蛋白单克隆抗体的制备及特性鉴定[J].细胞与分子免疫学杂志,2007,23(3):246-248. 被引量:5
  • 5Chang K, Pastan I. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers [J]. Proc NatlAcadSciUSA, 1996, 93(1): 136-140.
  • 6Bast R C Jr. , Badgwell D, Lu Z, et al. New tumor markers: CA125 and beyond[ J]. Int J Gynecol Cancer, 2005, 15 ( Suppl 3) : 274 - 281.
  • 7Rump A, Morikawa Y, Tanaka M, et al. Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion[ J]. 2004 , 279(10) : 9190 -9198.
  • 8Gubbels J A, Belisle J, Onda M, et al. Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors[ J]. Mol Cancer, 2006, 5 ( 1 ) : 50.
  • 9史惠蓉,寇歆馨.卵巢上皮性肿瘤组织及患者血清CA125检测[J].郑州大学学报(医学版),2008,43(2):324-326. 被引量:15
  • 10Yen M J, Hsu C Y, Mao T L, et al. Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinoma [J]. Clin Cancer Res, 2006, 12(3 Pt 1 ) : 827 -831.

二级参考文献21

  • 1张欣,吴令英,李晓江,李洪君,张蓉,刘丽影.盆腔良性肿物伴血清CA_(125)水平升高的临床意义[J].中华妇产科杂志,2005,40(3):178-182. 被引量:65
  • 2祝英杰,董菊颖,冯玉昆.血清CA125检测与卵巢癌[J].云南医药,2005,26(3):280-284. 被引量:8
  • 3吴小华,王小玲,张立芳,李利,王永军,郭燕红,郭清,杨波,黎海莉.卵巢上皮性肿瘤组织中间皮素和CA_(125)表达及其相关性研究[J].中华妇产科杂志,2005,40(10):709-711. 被引量:16
  • 4陈玉珍,何韶衡,周艳春,黄阗,刘岳宁,陈霖霏.抗人分泌性白细胞蛋白酶抑制剂单克隆抗体的制备与鉴定[J].细胞与分子免疫学杂志,2006,22(1):54-57. 被引量:2
  • 5Chang K, Pastan I. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Proc Natl Acad Sci USA, 1996, 93:136-140.
  • 6Hassan R, Bera T, Pastan I. Mesothelin: a new target for immunotherapy. Clin Cancer Res, 2004, 10: 3937-3942.
  • 7Rump A, Morikawa Y, Tanaka M, et al. Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion. J Biol Chem, 2004, 279:9190-9198.
  • 8Frierson HF Jr, Moskaluk CA, Powell SM, et al. Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas. Hum Pathol, 2003, 34:605-609.
  • 9Ordonez NG. Application of mesothelin immunostaining in tumor diagnosis. Am J Surg Pathol, 2003, 27:1418-1428.
  • 10Feeley KM, Wells M. Precursor lesions of ovarian epithelial malignancy. Histopathology, 2001, 38:87-95.

共引文献30

同被引文献38

  • 1吴小华,王小玲,张立芳,李利,王永军,郭燕红,郭清,杨波,黎海莉.卵巢上皮性肿瘤组织中间皮素和CA_(125)表达及其相关性研究[J].中华妇产科杂志,2005,40(10):709-711. 被引量:16
  • 2陈书成,刘雅坤,吴小华,单保恩,陈兴,孙东霞,王莉.抗人可溶性间皮素相关蛋白单克隆抗体的制备及特性鉴定[J].细胞与分子免疫学杂志,2007,23(3):246-248. 被引量:5
  • 3Pickel H, Lanhousen M, Stettner H, et al. The spread of ovarian cancer[J]. Baillieres Clin Obstet Gynaecol, 1989, 3:3-12.
  • 4Chang K,Pastan I. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas,and ovarian cancers [ J ]. Proc Natl Acad Sci USA, 1996,93 : 136-140.
  • 5Adachi W, ULanovsky H, Li Y, et al. Serial analysis of gene expression in the rat limbal and central corneal epithelium[ J ]. Invest Ophthalmol Vis Sci, 2006,47 : 3801- 3810.
  • 6Cheng WF, Hung CF, Chai CY, et al. Generation and characterization of an ascitogenic mesothelin-expressiong tumor model [ J ]. Cancer, 2007,110:420-231.
  • 7Uehara N, Mstsuoka Y, Tsubura A. Mesothelin promotes anchorage-independent growth and prevents anoikis via extracelluLar signal-regulated kinase signaling pathway in human breast cancer cells [ J ]. Mol Cancer Res,2008,6 : OF1 -OF5.
  • 8Zeimet AG, Marth C, Offner FA, et al. Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA125 [ J ]. Gynecol Oncol, 1996,62 : 384-389.
  • 9Hassan R, Kreitman R J, Pastan I, et al. Localization of mesothelin in epithelial ovarian cancer[ J]. Appl Immunohistochem Mol Morphol,2005 ,13 :243-247.
  • 10Rump A, Morikawa Y,Tanaka M, et al. Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion[ J ]. J Biol Chem,2004,279:9190-9198.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部